跳转至内容
Merck
  • Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells.

Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells.

Frontiers in oncology (2018-12-21)
Xianbin Zhang, Maria Schönrogge, Johanna Eichberg, Edgar Heinz Uwe Wendt, Simone Kumstel, Jan Stenzel, Tobias Lindner, Robert Jaster, Bernd Joachim Krause, Brigitte Vollmar, Dietmar Zechner
摘要

In this study we evaluated the interaction of pancreatic cancer cells, cancer-associated fibroblasts, and distinct drugs such as α-cyano-4-hydroxycinnamate, metformin, and gemcitabine. We observed that α-cyano-4-hydroxycinnamate as monotherapy or in combination with metformin could significantly induce collagen I deposition within the stromal reaction. Subsequently, we demonstrated that cancer-associated fibroblasts impaired the anti-proliferation efficacy of α-cyano-4-hydroxycinnamate, metformin and gemcitabine. Interestingly, inhibition of autophagy in these fibroblasts can augment the anti-proliferation effect of these chemotherapeutics in vitro and can reduce the tumor weight in a syngeneic pancreatic cancer model. These results suggest that inhibiting autophagy in cancer-associated fibroblasts may contribute to strategies targeting cancer.

材料
货号
品牌
产品描述

Sigma-Aldrich
单克隆抗 β-肌动蛋白抗体 小鼠抗, clone AC-15, ascites fluid
Roche
细胞增殖试ELISA, BrdU(比色法), sufficient for ≤1,000 tests
Sigma-Aldrich
抗小鼠IgG(全分子)-过氧化物酶 兔抗, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-Potassium Channel KV11.1 (HERG) Extracellular-FITC 兔抗, affinity isolated antibody, lyophilized powder